导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.18% | 478/2282 |
| 近一周 | -1.50% | 1604/2314 |
| 近一月 | -1.90% | 626/2307 |
| 近一季 | 2.04% | 269/2292 |
| 近半年 | 7.78% | 566/2290 |
| 近一年 | 9.06% | 763/2265 |
| 近两年 | 80.44% | 555/2173 |
| 近三年 | 39.73% | 703/2101 |
| 成立以来 | 551.86% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.43% 711/2333 |
12.99% 970/2331 |
- - |
- - |
| 2025 | 26.81% 966/2338 |
4.77% 598/2326 |
5.44% 437/2347 |
22.80% 836/2344 |
-6.52% 2062/2338 |
| 2024 | -3.16% 1741/2331 |
-5.99% 1734/2322 |
-6.56% 1915/2326 |
10.00% 868/2317 |
0.22% 998/2331 |
| 2023 | -6.24% 951/2323 |
2.54% 1013/2290 |
-2.68% 1225/2303 |
-6.96% 1367/2318 |
0.99% 210/2330 |
| 2022 | -14.53% 985/2294 |
-16.38% 1365/2227 |
6.20% 880/2269 |
-8.28% 1087/2294 |
4.93% 249/2300 |
| 2021 | 6.43% 1117/2202 |
5.94% 59/1745 |
-0.11% 1654/2232 |
-6.65% 1402/2560 |
7.73% 281/2208 |
| 2020 | 51.78% 686/2082 |
8.73% 74/1036 |
31.57% 205/1256 |
7.83% 845/1472 |
-1.60% 1445/1690 |
| 2019 | 56.23% 206/1973 |
21.70% 1235/3054 |
0.66% 1034/3201 |
12.37% 135/939 |
13.49% 148/1014 |
| 2018 | -15.91% 865/1913 |
- - |
- - |
- - |
-4.94% 1220/2977 |
| 2017 | 10.04% 539/1885 |
- - |
- - |
- - |
- - |
| 2016 | -3.27% 501/1510 |
- - |
- - |
- - |
- - |
| 2015 | 74.96% 24/849 |
- - |
- - |
- - |
- - |
| 2014 | 14.96% 306/432 |
- - |
- - |
- - |
- - |
| 2013 | 23.17% 102/398 |
- - |
- - |
- - |
- - |
| 2012 | 12.30% 50/459 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 前海开源医疗健康A | 1.3221 | 43.69% |
| 前海开源医疗健康C | 1.3108 | 43.67% |
| 中信建投医改混合A | 1.9439 | 35.61% |
| 中信建投医改混合C | 1.5821 | 35.48% |
| 国投瑞银医疗保健混合C | 1.1874 | 26.59% |
| 易方达供给改革混合 | 8.1305 | 24.38% |
| 国投瑞银医疗保健混合A | 1.2015 | 24.11% |
| 浦银安盛医疗健康混合A | 1.3373 | 24.10% |
| 先锋聚优A | 1.3980 | 23.90% |
| 先锋聚优C | 1.4204 | 23.84% |
| 国投瑞银新兴产业混合(LOF)A VS. 德邦优化A(770001) |